Ardelyx, Inc. (ARDX) stock
ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3058% below fair value
$3.18+0.11 (+3.58%)
Close on Nov 17, 2026Market cap $792.42MP/E –Yield –
Ardelyx pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Ardelyx's pe ratio was 819.0× on Oct 30, 2015.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2015 | Oct 30, 2015 | 819.0× | – |
See a number that looks wrong?